市場調查報告書

局部藥物輸送的全球市場:類型(半固體·液體·個體·經皮),途徑,使用設施,各地區 - 市場趨勢,競爭情形,佔有率,預測(2015年∼2025年)

Global Topical Drug Delivery Market by Type (Semisolids, Liquids, Solids, Transdermal Products), Route, Facility of Use, By Region ; Trend Analysis, Competitive Market Share & Forecast, 2015-2025

出版商 Blueweave Consulting & Research Private Limited 商品編碼 924190
出版日期 內容資訊 英文 120 Pages
商品交期: 最快1-2個工作天內
價格
局部藥物輸送的全球市場:類型(半固體·液體·個體·經皮),途徑,使用設施,各地區 - 市場趨勢,競爭情形,佔有率,預測(2015年∼2025年) Global Topical Drug Delivery Market by Type (Semisolids, Liquids, Solids, Transdermal Products), Route, Facility of Use, By Region ; Trend Analysis, Competitive Market Share & Forecast, 2015-2025
出版日期: 2019年10月25日內容資訊: 英文 120 Pages
簡介

全球局部藥物輸送市場在2019年∼2025年間預測將以5.4%的年複合成長率成長。皮膚和眼部疾病的流行以及生活方式的改變造成牛皮癬和皮膚癌增加等,正在推動這一市場的增長。

本報告提供全球局部藥物輸送市場調查,提供市場概要,各類型·給藥途徑·使用設施·各地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,市場機會,佔有率,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 研究組成架構

  • 調查目的
  • 產品概要
  • 市場區隔

第2章 調查方法

  • 定性的調查
  • 定量的調查
  • 各地區的主要受訪者
  • 市場規模的預測
  • 調查的前提
  • 市場分析與資料三角測量

第3章 摘要整理

第4章 產業考察

  • 價值鏈分析
  • 市場影響要素分析
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 技術概要
  • 法律規範
  • 企業的市場佔有率分析
  • 競爭企業分析
  • 波特的五力分析
  • PEST分析
  • 策略性預測

第5章 全球局部藥物輸送市場概要

  • 市場規模與預測
  • 市場佔有率與預測
    • 各產品
    • 各類型
    • 各給藥途徑
    • 各使用設施
    • 各地區

第6章 北美的局部藥物輸送市場

  • 市場規模與預測
  • 市場佔有率與預測
    • 各產品
    • 各類型
    • 各給藥途徑
    • 各使用設施
    • 各地區

第7章 歐洲的局部藥物輸送市場

  • 市場規模與預測
  • 市場佔有率與預測
    • 各產品
    • 各類型
    • 各給藥途徑
    • 各使用設施
    • 各地區

第8章 亞太地區的局部藥物輸送市場

  • 市場規模與預測
  • 市場佔有率與預測
    • 各產品
    • 各類型
    • 各給藥途徑
    • 各使用設施
    • 各地區

第9章 南美的局部藥物輸送市場

  • 市場規模與預測
  • 市場佔有率與預測
    • 各產品
    • 各類型
    • 各給藥途徑
    • 各使用設施
    • 各地區

第10章 中東·非洲的局部藥物輸送市場

  • 市場規模與預測
  • 市場佔有率與預測
    • 各產品
    • 各類型
    • 各給藥途徑
    • 各使用設施
    • 各地區

第11章 企業簡介

  • Glaxosmithkline
  • Janssen Global Services (A Subsidiary of Johnson & Johnson)
  • Bausch Health Companies
  • Merck & Co.
  • Bayer AG
  • 久光製藥
  • Nestle Sa
  • Novartis AG
  • Glenmark Pharmaceuticals
  • Cipla
  • 其他

第12章 策略建議

目錄
Product Code: BWC19313

BlueWeave Consulting review study of the Topical Drug Delivery Market anticipated to propel with a significant CAGR of 5.4% in the forecasted period of 2019-2025. The increasing rate of skin and eye disease prevalence is becoming one of the factors to drive growth in the global topical drug delivery market. The rising trend of skin-related diseases such as psoriasis, cancer, etc. due to changing lifestyle patterns is contributing to an increase in the demand for topical drug delivery in the market with a significant growth rate. Rising alternative modes of drug delivery such as injectable, oral, and pulmonary of the drug delivery care sector are anticipated to hamper the growth of topical drug delivery market in the upcoming years.

Growing prevalence of diabetes expected to dominate the global topical drug delivery market

The increasing rate of disposable income, preference shifts in eating habits are the key factor contributing to diabetes prevalence. The rising rate of diabetes prevalence is the key factor anticipated to drive the growth and demand of topical drug delivery system in the market with eye care segmentation. semi-solid formulation segment is expected to dominate the global topical drug delivery market due to an advantage factor such as easy drug release, patient acceptability, and multiple applications in the upcoming years with the commendable growth rate.

Technological advancement in the homecare setting is the key factor propelling the growth in the market in the forecast period

Technological advancement in the healthcare sector, coupled with increasing healthcare expenditure anticipated to dominate the global market in the upcoming years. Properties such as deep penetration of drugs within the body, preference shift of patient due to non-invasive nature and increasing rate of geriatric population, R&D, biologics delivery via a transdermal route with small player's acquisition expected to drive the global topical drug delivery market in the upcoming years with a significant growth rate. The market is anticipated to dominate by homecare setting as a homecare setting to eliminate the hospital visit to save patient time and money. The rising affordability and convenience are the key factor expected to propel the growth during the forecast period of 2019-2025.

Topical Drug Delivery Market: competitive landscape

Some of the major industry players are Glaxosmithkline, Janssen Global Services (A Subsidiary of Johnson & Johnson), Bausch Health Companies, Merck & Co., Bayer AG, Hisamitsu Pharmaceutical, Nestle Sa, Novartis AG, Glenmark Pharmaceuticals, Cipla and Other Prominent Player.

Don't miss the business opportunity of topical drug delivery Market. Consult to our analyst and gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides the growth potential, upcoming trends and statistics of nutraceutical products market size & forecast. The report promises to provide state-of-the-art technology of Topical Drug Delivery Market and industry insights which help decision makers to take sound strategic decisions. Furthermore, the report also analyzes the market drivers and challenges and competitive analysis of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1. Primary & Secondary Sources
  • 2.3. Breakdown of Primary Research Respondents, By Region
    • 2.3.1. Secondary Research
    • 2.3.2. Primary Research
  • 2.4. Breakdown of Primary Research Respondents, By Industry Participants
  • 2.5. Market Size Estimation
  • 2.6. Assumption for the Study
  • 2.7. Market Breakdown & Data Triangulation

3. Executive Summary

4. Global Topical Drug Delivery Market - Industry Insights

  • 4.1. Value Chain Analysis
  • 4.2. DROC Analysis
    • 4.2.1. Growth Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. Technological Landscape
  • 4.4. Regulatory Framework
  • 4.5. Company Market Share Analysis,2018
  • 4.6. Competitor Analysis, 2018
  • 4.7. Porter's Five Forces Analysis
  • 4.8. Pest Analysis
  • 4.9. Strategic Outlook

5. Global Topical Drug Delivery Market Overview

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast, 2015 - 2025
    • 5.2.1. By Product
      • 5.2.1.1.1. Semi-Solid Formulations
      • 5.2.1.1.1.1. Creams
      • 5.2.1.1.1.2. Ointments
      • 5.2.1.1.1.3. Lotions
      • 5.2.1.1.1.4. Gels
      • 5.2.1.1.1.5. Pastes
      • 5.2.1.2. Liquid Formulation
      • 5.2.1.2.1.1. Suspensions
      • 5.2.1.2.1.2. Solutions
      • 5.2.1.3. Solid Formulation
      • 5.2.1.3.1.1. Powders
      • 5.2.1.3.1.2. Suppositories
      • 5.2.1.4. Transdermal Products
      • 5.2.1.4.1.1. Transdermal Patches
      • 5.2.1.4.1.2. Transdermal Semi-Solid
    • 5.2.2. By Type
      • 5.2.2.1. Soft & Elastic Braces and Supports
      • 5.2.2.2. Hard & Rigid Braces and Supports
      • 5.2.2.3. Hinged Braces and Supports
    • 5.2.3. By Route of Administration
      • 5.2.3.1. Dermal Drug Delivery
      • 5.2.3.2. Ophthalmic Drug Delivery
      • 5.2.3.3. Rectal Drug Delivery
      • 5.2.3.4. Vaginal Drug Delivery
      • 5.2.3.5. Nasal Drug Delivery
    • 5.2.4. By Facility
    • 5.2.5. Home Care Setting
    • 5.2.6. Hospitals & Clinics
    • 5.2.7. Burn Centers
  • 5.3. By Region
      • 5.3.1.1. North America
      • 5.3.1.2. Europe
      • 5.3.1.3. Asia-Pacific
      • 5.3.1.4. Latin America
      • 5.3.1.5. Middle East and Africa

6. North America Topical Drug Delivery Market

  • 6.1. Market Estimates & Forecast, 2015 - 2025
    • 6.1.1. By Product
    • 6.1.2. By Type
    • 6.1.3. By Route of Administration
    • 6.1.4. By Facility
    • 6.1.5. By Country
      • 6.1.5.1. US
      • 6.1.5.2. Canada

7. Europe Topical Drug Delivery Market

  • 7.1. Market Estimates & Forecast, 2015 - 2025
    • 7.1.1. By Product
    • 7.1.2. By Type
    • 7.1.3. By Route of Administration
    • 7.1.4. By Facility
    • 7.1.5. By Country
      • 7.1.5.1. UK
      • 7.1.5.2. Germany
      • 7.1.5.3. France
      • 7.1.5.4. Russia
      • 7.1.5.5. Spain

8. Asia-Pacific Topical Drug Delivery Market

  • 8.1. Market Estimates & Forecast, 2015 - 2025
    • 8.1.1. By Product
    • 8.1.2. By Type
    • 8.1.3. By Route of Administration
    • 8.1.4. By Facility
    • 8.1.5. By Country
      • 8.1.5.1. China
      • 8.1.5.2. India
      • 8.1.5.3. Japan
      • 8.1.5.4. South Korea

9. Latin America Topical Drug Delivery Market

  • 9.1. Market Estimates & Forecast, 2015 - 2025
    • 9.1.1. By Product
    • 9.1.2. By Type
    • 9.1.3. By Route of Administration
    • 9.1.4. By Facility
    • 9.1.5. By Country
      • 9.1.5.1. Brazil
      • 9.1.5.2. Mexico

10. Middle East & Africa Topical Drug Delivery Market

  • 10.1. Market Estimates & Forecast, 2015 - 2025
    • 10.1.1. By Product
    • 10.1.2. By Type
    • 10.1.3. By Route of Administration
    • 10.1.4. By Facility
    • 10.1.5. By Country
      • 10.1.5.1. Saudi Arabia
      • 10.1.5.2. UAE
      • 10.1.5.3. South Africa

11. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

  • 11.1. Glaxosmithkline
  • 11.2. Janssen Global Services (A Subsidiary of Johnson & Johnson)
  • 11.3. Bausch Health Companies
  • 11.4. Merck & Co.
  • 11.5. Bayer AG
  • 11.6. Hisamitsu Pharmaceutical
  • 11.7. Nestle Sa
  • 11.8. Novartis AG
  • 11.9. Glenmark Pharmaceuticals
  • 11.10. Cipla
  • 11.11. Other Prominent Player

12. Strategic Recommendation

  • Financial Details Not Be Captured in Case of Unlisted Companies
  • *The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable.